Construction and Production of HIV-VLP Harboring MPER-V3 for Potential Vaccine Study

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|15|6|434-439

ISSN： 1570-162X

Source： Current HIV Research, Vol.15, Iss.6, 2018-01, pp. : 434-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First phase-3 HIV vaccine trial-hype or hope?

By Morris K.  

The Lancet Infectious Diseases, Vol. 3, Iss. 4, 2003-04 ,pp. : 186-186

Elsevier

Access to resources Recommend Favorite

High hopes for HIV vaccine

By Ahmad K.  

The Lancet Infectious Diseases, Vol. 3, Iss. 2, 2003-02 ,pp. : 62-62

Elsevier

Access to resources Recommend Favorite

Application of SCR Priming VLP Boosting as a Novel Vaccination Strategy Against HIV-1

By  

Current HIV Research, Vol. 9, Iss. 3, 2011-04 ,pp. : 140-147

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infection

By Fincham Dylan   Kagee Ashraf   Swartz Leslie  

AIDS Care, Vol. 22, Iss. 4, 2010-04 ,pp. : 452-461

Routledge Ltd

Access to resources Recommend Favorite

Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies

By Dhalla Shayesta   Poole Gary  

AIDS Care, Vol. 23, Iss. 11, 2011-11 ,pp. : 1430-1447

Routledge Ltd

Access to resources Recommend Favorite